Over the last decade, as the Institute for Clinical and Economic Review (ICER) has estimated the cost-effectiveness of newly approved drugs—and often declared them overpriced—companies in the industry ...

Two popular medications used in the fight against obesity—semaglutide (Wegovy; Novo Nordisk) and tirzepatide (Zepbound; Eli Lilly)—are priced too high to be considered cost-effective by currently ...

According to reports from Ukraine’s air force, Russia launched more than 19,000 missiles, including over 14,700 one-way attack drones, at targets in Ukraine from September 28, 2022, through December ...

A new technology for management of diabetes is cost-effective for patients in the US with type 1 diabetes compared with traditional treatments. Objectives: Advances in diabetes technology have led to ...

Multicancer early detection testing results in extended life-years and reduced cancer treatment costs through earlier diagnosis, leading to a cost-effective option in cancer screening. Objectives: ...

A new analysis from the Institute for Clinical and Economic Review has found that blockbuster GLP-1 drugs from Novo Nordisk and Eli Lilly offer substantial health benefits and are a cost-effective ...

Amid a yearslong wave of enthusiasm and uptake for Eli Lilly and Novo Nordisk's blockbuster obesity medicines, the drugs have scored a strong endorsement from an independent U.S. cost watchdog. In a ...

Recruitment is more than posting job ads and conducting interviews—it’s about aligning your recruitment strategy with your company’s goals, hiring budget and workforce needs. Businesses typically rely ...

Wegovy (semaglutide) is a self-injectable prescription weight loss medicine that has helped people with obesity. It is to be used in conjunction with an appropriate dietary regimen and increased ...